Acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) After proper administration of acetylcysteine, an increased volume of liquified bronchial secretions may occur
Neumann, P., Lenz, D
Is Tirzepatide with B12 effective for medical weight loss
Hsu DY, Brieva J, Silverberg NB, et al
GLP-1 receptor agonists and coronary arteries: from mechanisms to events
When it comes to medical weight loss, two of the biggest names in the conversation are semaglutide and Mounjaro
